Novoheart to Acquire Xellera Therapeutics
May 28, 2019 10:47 ET
|
Novoheart Holdings Inc.
Xellera Therapeutics Limited will accelerate the progression of Novoheart’s current business scopeSignificantly enhances Novoheart’s liquidity, gaining access to approximately C$22,500,000 cash ...
Novoheart Holdings Inc. Reports Third Quarter 2019 Financial Results and Stock Option Grants
May 17, 2019 17:00 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and nine months ended March 31, 2019....
Novoheart Announces Revolving Credit Facility
April 11, 2019 02:45 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, April 10, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that its subsidiary, Novoheart Limited (Hong...
Novoheart Grants Stock Options
March 06, 2019 20:00 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, March 06, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that it has granted incentive stock options to...
Novoheart Holdings Inc. Reports Second Quarter 2019 Financial Results and Announces AGM Results
March 01, 2019 19:50 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, March 01, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and six months ended December 31, 2018....
Novoheart Grants Stock Options and RSUs
February 08, 2019 17:43 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that it has granted incentive stock options to...
Novoheart Provides Corporate Update
January 07, 2019 08:00 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced today that Iris Lo has tendered her resignation...
Novoheart Holdings Inc. Reports First Quarter 2019 Financial Results
November 22, 2018 20:21 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended September 30, 2018....
Novoheart to Generate USD $1.7m From Strategic Partnership to Build Good Manufacturing Practice Facility to Create Clinical-Grade Human Stem Cell Libraries
October 31, 2018 04:42 ET
|
Novoheart Holdings Inc.
Phase 1 (6 to 9 months) of potential multi-year effort Service agreement to generate US$1.7M of revenue Novoheart will have exclusive rights to the iPSC cell lines for cardiac applicationsPartnership...
Novoheart Recruits Notable Pharma Industry Executive, Bernard Fermini, Ph.D. as Chief R&D Officer
September 24, 2018 03:05 ET
|
Novoheart Holdings Inc.
VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, announced today that it has...